Amrize Ltd (AMRZ) Financials, Dividends & Stock Info
Explore comprehensive financial data for Amrize Ltd, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Amrize Ltd (AMRZ) is a construction materials company.
Amrize Ltd Financial Health ScoreFY2025
Moderate health; several metrics need attention
-8 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Amrize Ltd Recent Events
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
About Amrize Ltd
- Industry
- Construction Materials
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Profitability Data Under ReviewProfitability metrics are being verified. Some SEC filing data may require additional validation.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Amrize Ltd 3-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2023| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $11.8B(+0.9%) | $11.7B(+0.2%) | $11.7B |
| Net Income | $1.2B(-7.0%) | $1.3B(+33.3%) | $956.0M |
| Total Assets | $24.2B | $23.8B | - |
| Total Debt | - | - | - |
| Total Equity | $13.3B | $9.9B | $9.2B |
| Profit Margin | 10.0% | 10.9% | 8.2% |
| ROE | 8.9% | 12.8% | 10.4% |
| ROA | 4.9% | 5.3% | - |
Quarterly Financials
Last 7 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $8.9B | $5.4B | - | $3.4B | $3.2B | - |
| Net Income | $-87,000,000 | $983.0M | $430.0M | - | $553.0M | $474.0M | - |
| Total Assets | $24.2B | $23.8B | $23.8B | - | - | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
5 insiders purchased shares worth $2.7M in the last 30 days. Revenue grew +0.9% YoY and profit margin at 10.0%. Signal strength: 40/100.
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Amrize Ltd Free Cash Flow & Dividend Coverage
Generates approximately $4M in free cash flow per day.
Cash Flow History
FY2023 - FY2025| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating CF | $2.0B | $2.3B | $2.2B |
| CapEx | -$630.0M | -$642.0M | -$788.0M |
| Free Cash Flow | $1.4B | $1.6B | $1.4B |
| FCF Margin | 12.0% | 14.0% | 12.0% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Amrize Ltd Risk Factors
Common risks for Materials
Risk factors shown are common to the Materials and may not reflect all risks specific to AMRZ. See SEC filings for complete disclosure.
Amrize Ltd FAQ
Does Amrize Ltd pay dividends?
No, Amrize Ltd (AMRZ) does not currently pay dividends to shareholders.
What is Amrize Ltd's financial health score?
Amrize Ltd has a financial health score of 66/100 (Grade: C), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Amrize Ltd financial data are available?
3 years of financial data are available for Amrize Ltd from FY2023 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.